Back to Search
Start Over
Merck, Daiichi rack up phase 3 ADC lung cancer win but report 2 deaths, immature OS data.
- Source :
- FierceBiotech; 9/17/2024, pN.PAG-N.PAG, 1p
- Publication Year :
- 2024
-
Abstract
- The trial hit its primary endpoint, boosting plans to take a second shot at FDA approval, but two more people died and the OS data are immature. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 179753769